Sanjay Chanda

Affiliations

  • Chief Development Officer at An2 Therapeutics Inc. (ANTX), 2024-03-29
  • Svp, Drug Development at Anacor Pharmaceuticals Inc. (ANAC), 2015-03-05
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ANAC $45.00 48 Officer 29,087 2015-03-04 Filing
ANAC $45.00 4,952 Officer 29,087 2015-03-04 Filing
ANAC $35.00 5,000 Officer 3,995 2014-11-26 Filing
ANAC $24.25 4,953 Officer 3,995 2014-09-10 Filing
ANAC $24.25 5,047 Officer 3,995 2014-09-10 Filing